Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 4, 1999, Pages 267-277

  Thøgersen, Vibeke Bech ^a   Jorgensen P E ^a   Sorensen B S ^a   Bross, P ^a   Orntoft T ^a   Wolf, H ^a   Nexo E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; EGFr; Human; TGF

Indexed keywords

GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; SURVIVAL TIME; TUMOR BIOPSY;

EID: 0001442675     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185634     Document Type: Article

References (38)

1. 1 Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
2. 2 Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 1995; 35: 115-32.
3. 3 Gavrilovic J, Moens G, Thiery JP, Jouanneau J. Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix degrading potential in a rat bladder carcinoma cell line. Cell Regul 1990; 1: 1003-14.
4. 4 Ravery V, Colombel M, Popov Z, Bastuji S, Patard JJ, Bellot J, Abbou CC, Fradet Y, Chopin DK. Prognostic value of epidermal growth factor receptor, T138 and T43 expression in bladder cancer. Br J Cancer 1995; 71: 196-200.
5. 5 Mellon JK, Cook S, Chambers P, Neal DE. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor. Br J Cancer 1996; 73: 654-8.
6. 6 Messing EM, Hanson P, Ulrich P, Erturk E. Epidermal growth factor interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 1987; 138: 1329-35.
7. 7 Chow NH, Liu HS, Yang HB, Chan SH, Su IJ. Expression patterns of erb-B receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Arch 1997; 430: 461-6.
8. 8 Chow NH, Liu HS, Lee EI, Chang CJ, Chan SH, Cheng HL, Tzai TS, Lin JS. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 1997; 17: 1293-6.
9. 9 Mellon K, Wright C, Kelly P, Horne CH, Neal DE. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 1995; 153: 919-25.
10. 10 Messing EM. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990; 50: 2530-7.
11. 11 Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR, Harris AL. Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding. J Urol 1989; 141: 517-21.
12. 12 Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR, Harris AL. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1985; 1: 366-8.
13. 13 Ravery V, Grignon D, Angulo J, Pontes E, Montie J, Crissman J, Chopin D. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erb-B2 in the progression of invasive bladder cancer. Urol Res 1997; 25: 91-7.
14. 14 Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990; 65: 1619-25.
15. 15 Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE, Harris AL, Waterfield MD. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 1987; 56: 533-7.
16. 16 Wood DP Jr, Fair WR, Chaganti RS. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J Urol 1992; 147: 274-7.
17. 17 Chow NH, Tzai TS, Cheng PE, Chang CJ, Lin JS, Tang MJ. An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 1994; 22: 221-5.
18. 18 Fuse H, Mizuno I, Sakamoto M, Katayama T. Epidermal growth factor in urine from the patients with urothelial tumors. Urol Int 1992, 48: 261-4.
19. 19 Kristensen JK, Lose G, Lund F, Nexo E. Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol 1988; 14: 313-4.
20. 20 Chomczynski P, Sacchi N. Singlestep method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-9.
21. 21 Sambrook J, Fritsch EF, Maniatiatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab, 1989; 7.01-7.87.
22. 22 Thogersen VB, Bross P, Gregersen N, Nexo E. Quantitative analysis of the human epidermal growth factor receptor messenger RNA using reverse transcription-PCR a methodological study of imprecision. Clin Chem 1998; 44: 1344-6.
23. 23 Haley J, Whittle N, Bennet P, Kinchington D, Ullrich A, Waterfield M. The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res 1987; 1: 375-96.
24. 24 Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418-25.
25. 25 Lichtsteiner S, Tjian R. Cloning and properties of the Cacnorhabditis clegans TATA box binding protein. Proc Natl Acad Sci USA 1993; 90: 9673-7.
26. 26 Qian JF, Feingold J, Stoll C, May E. Transforming growth factor-alpha: characterization of the BamIII, RsaI, and TaqI polymorphic regions. Am J Hum Genet 1993; 53: 168-75.
27. 27 Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexo E. A sensitive enzymelinked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 1995; 72: 1487-93.
28. 28 Jorgensen PE, Vinter Jensen L, Nexo E. An immunoassay designed to quantitate different molecular forms of rat urinary epidermal growth factor with equimolar potency: application on fresh rat urine. Scand J Clin Lab Invest 1996; 56: 25-36.
29. 29 Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 1994; 57: 508-14.
30. 30 Lipponen PK, Eskelinen MJ. Expression of pS2 protein in transitional cell bladder tumours. J Pathol 1994; 173: 327-32.
31. 31 Witjes JA, Umbas R, Debruyne FM, Schalken JA. Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer. J Urol 1995; 154: 2185-9.
32. 32 Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CH, Neal DE. Expression of mutant p53, c-erb-B2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991; 63: 967-70.
33. 33 Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katsuta N, Mori S. Expression of c-erb-B2 gene product in urinary bladder cancer. J Urol 1991; 145: 423-7.
34. 34 Press MF, Hung G, Godolphin W, Slamon DJ. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994; 54: 2771-7.
35. 35 Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LW. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 1993; 53: 5300-7.
36. 36 Wolf H. Neal DE, editors. Tumours in urology. Tumour progression in superficial bladder cancer. London: Springer-Verlag, 1994, 3: 47-64.
37. 37 Vollmer RT, Humphrey PA, Swanson PE, Wick MR, Hudson ML. Invasion of the bladder by transitional cell carcinoma: its relation to nistologic grade and expression of p53, MIBI, c-erb B2, epidermal growth factor receptor, and bcl-2. Cancer 1998; 82: 715-23.
38. 38 Turkeri LN, Erton ML, Cevik I, Akdas A. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer. Urology 1998; 51: 645-9.